PlusTherapeuticsInc . (NASDAQ:PSTV) Stock Price Down 49.5%

PlusTherapeuticsInc . (NASDAQ:PSTV)’s stock price dropped 49.5% on Monday . The company traded as low as $3.56 and last traded at $4.05, approximately 6,867,158 shares changed hands during trading. An increase of 3,487% from the average daily volume of 191,457 shares. The stock had previously closed at $8.02.

Separately, ValuEngine raised shares of PlusTherapeuticsInc . from a “hold” rating to a “buy” rating in a research report on Tuesday.

The company has a quick ratio of 0.37, a current ratio of 0.38 and a debt-to-equity ratio of 0.39.



PlusTherapeuticsInc . (NASDAQ:PSTV) last posted its quarterly earnings data on Thursday, August 15th. The company reported ($5.12) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($9.75) by $4.63. The firm had revenue of $0.30 million during the quarter. PlusTherapeuticsInc . had a negative net margin of 492.45% and a negative return on equity of 546.87%.

About PlusTherapeuticsInc . (NASDAQ:PSTV)

Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, engages in developing treatments for cancer and other diseases in the United States. The company's lead product candidate in pipeline is DocePLUS, an albumin-stabilized PEGylated liposomal formulation of docetaxel for the treatment of small cell lung cancer.

Featured Story: Street Name

Receive News & Ratings for PlusTherapeuticsInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PlusTherapeuticsInc . and related companies with MarketBeat.com's FREE daily email newsletter.